A target trial emulation with an extension to subgroups: an example for relapsing-remitting multiple sclerosis

First published 18/06/2024

Last updated 16/09/2024

EU PAS number:

EUPAS1000000135

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

HARPER protocol V3.pdf

English (521.78 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents